News about Global Pharma

Olympus Appoints Slawek Kierner as CDO - Smart Connected Care

Olympus Appoints Slawek Kierner as CDO - Smart Connected Care

Olympus Corporation (Olympus) announced the appointment of Slawek Kierner to the role of Chief Digital Officer - Smart Connected Care (CDO-SCC), effective immediately.

Global Pharma | 19/05/2025 | By Manvi 194

Trax Surgical Receives FDA Clearance for LINKT Compression Staple System

Trax Surgical Receives FDA Clearance for LINKT Compression Staple System

Massachusetts based Trax Surgical, LLC, an orthopedic product development and distribution company principally serving the needs of the orthopedic extremities market, announced that they received FDA 510(k) clearance to market the LINKT™ Compression Staple System.

Global Pharma | 19/05/2025 | By Manvi 155

India's Pharma Sector Records 7.8 Percent Growth in April 2025, Catering to 20 Percent of Global Need

India's Pharma Sector Records 7.8 Percent Growth in April 2025, Catering to 20 Percent of Global Need

India’s pharmaceutical industry recorded 7.8 percent year-on-year growth in April 2025, driven by global demand, new product launches, and robust government initiatives positioning the country as a global hub for affordable, high-quality healthcare.

Global Pharma | 19/05/2025 | By Manvi 851

Fzata Announces Joining of Gianna Arnold on Board of Directors

Fzata Announces Joining of Gianna Arnold on Board of Directors

The pharmaceutical company, Fzata, Inc., informed about the appointment of Gianna Arnold on the Board of Directors. The company developed a next-generation oral biologics modality called Bioengineered Probiotic Yeast Medicines (BioPYM).

Global Pharma | 19/05/2025 | By Manvi 285

Endo Expands ADRENALIN RTU Premixed Bag Portfolio with New Concentration Option

Endo Expands ADRENALIN RTU Premixed Bag Portfolio with New Concentration Option

Endo, Inc. has announced the launch of an FDA-approved ADRENALIN, currently the only commercially available manufacturer-prepared epinephrine premixed intravenous (IV) bag.

Global Pharma | 17/05/2025 | By Manvi 209

ISSS Endorses Hyoid Suspension as Safe, Effective Treatment for Obstructive Sleep Apnea

ISSS Endorses Hyoid Suspension as Safe, Effective Treatment for Obstructive Sleep Apnea

Following a rigorous review of clinical research, the International Surgical Sleep Society (ISSS) recently published a position statement supporting hyoid suspension as a safe and effective approach in the medical and surgical management of obstructive sleep apnea (OSA).

Global Pharma | 17/05/2025 | By Manvi 454

Maness Veteran Medical's NEUBIE Device Now Available to VA, DoD via Federal Supply Schedule

Maness Veteran Medical's NEUBIE Device Now Available to VA, DoD via Federal Supply Schedule

Maness Veteran Medical (MVM) announce a major step forward in the future of veteran care: the NEUBIE (Neuro-Bio-Electric Stimulator) device is now officially available through the Federal Supply Schedule (FSS), contract 36F79725D0083.

Global Pharma | 17/05/2025 | By Manvi 329

Sun Pharma Secures FDA Approval for Next-Generation BLU-U Blue Light Therapy Device for Actinic Keratosis

Sun Pharma Secures FDA Approval for Next-Generation BLU-U Blue Light Therapy Device for Actinic Keratosis

Sun Pharma has received FDA approval for its next-generation LED BLU-U Blue Light Photodynamic Therapy Illuminator for treating actinic keratosis.

Global Pharma | 17/05/2025 | By Manvi 502

Nordic Bioscience Introduces Novel Endotrophin Assay

Nordic Bioscience Introduces Novel Endotrophin Assay

Nordic Bioscience has launched nordicEndotrophin, a fully automated, high-precision assay that quantifies the intact 77-amino-acid Endotrophin hormone, enhancing risk stratification and treatment monitoring in fibrosis, cancer, and chronic diseases.

Global Pharma | 16/05/2025 | By Manvi 156

Senores Pharmaceuticals Reports 174 Percent Revenue Growth in Emerging Markets in FY25

Senores Pharmaceuticals Reports 174 Percent Revenue Growth in Emerging Markets in FY25

Senores Pharmaceuticals Ltd. reported a robust 69 percent year-on-year growth in regulated market revenue to INR 244.8 crore in FY25, alongside a 174 percent surge in emerging market revenue, reflecting strong momentum across its global pharmaceutical operations.

Global Pharma | 16/05/2025 | By Manvi 397

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members